Brochure: Get to the Clinic First with Best-In-Class Antibody Therapeutics
Find out how Opto™ Plasma B Discovery on the Beacon optofluidic system allows Pharma to succeed against difficult targets and deliver best-in-class antibody therapeutics.
Brochure: Lead Molecules Against Any Target. At Record Pace.
Find out how Opto™ Plasma B Discovery on the Beacon optofluidic system allows CROs to scale their business and rapidly deliver lead molecules even against difficult targets.
Datasheet: Adherent Cell Kit
Learn more about how the Adherent Cell Kit enables the isolation, growth, monitoring and recovery of adherent cells on the Beacon® and Lightning™ Optofluidic systems.
App Note: Bring Product Quality Assessment into Early Clone Selection with the Opto™ Assure Aggregation Assay
Read this application note to learn more about how to get early, multi-parameter assessment of clones with the Opto Assure assay series.
Customer Spotlight: Genovac on Antibody Discovery
Find out how Genovac is delivering 10-fold more lead candidates against difficult targets.
Brochure: Get to Market Faster with the Opto CLD Workflow
Find out how the Opto CLD workflow sets a new standard for quality, capacity, and speed in cell line development to let BioPharma get more molecules to the clinic faster.
Brochure: Increase CDMO Revenue with the Opto CLD Workflow
Find our how the Opto CLD workflow sets a new standard for quality, capacity, and speed in cell line development and allows CDMOs to scale operations and drive new business.
Webinar: Leveraging Innovative Technologies to Accelerate Biologics Development
At the 2021 BPS EU virtual conference, Beacon user Joaquina Mascarenhas, PhD, at Thermo Fisher Scientific shares how the Berkeley Lights Platform enables their cell line development to move at world class speed and select the best clones.
Webinar: Characterizing T Cell Functionality on the Berkeley Lights Lightning Platform
Hear from Dr. Anthony Zamora, Assistant Professor at Medical College of Wisconsin, discusses how the Lightning system enables rapid functional characterization of T cells and allows for thousands of single cells to be isolated, cultured, assayed, and exported for further analysis.
Webinar: Looking to the Future: What’s next in Antibody Therapeutics
At the 2021 AE&T EU conference, Tracey Mullens, CEO of Abveris, and Brian Walters, CEO of Genovac, joined John Proctor, SVP Antibody Therapeutics, for a discussion about the evolving landscape of antibody therapeutics, the technologies they have turned to address today’s complex targets, and how they are preparing for tomorrow’s challenges.
Webinar: Accelerating Discovery and Development of Antibody Therapeutics
Hear from BLI experts Renee Tobias and Anupam Singhal about the unique benefits to leveraging a single platform for both the identification of promising candidates and the production of leading therapeutic molecules.
App Note: Rapid Single-Cell Cloning and Screening to Identify Superior Reporter Cell Lines Using the Lightning™ Optofluidic System
Read this application note to learn more about how to screen reporter cell lines at the single-cell level in only 3 days.
App Note: Real-Time Monitoring of Chemical and Biological Induction of Apoptosis on Clonal Cells Using the Lightning™ System
Read this application note to learn more about observing apoptosis at the single-cell level across 1,000 clonal cells.
Poster: Multi-omic Analysis for Directly Linking T Cell Phenotype to Gene Expression
Find out how the OptoSeq™ Single Cell 3′ mRNA kit workflow enables automated, on-chip, bead-based capture of mRNA for reverse transcription to directly link phenotype to gene expression.
Webinar: Multi-omic Profiling of T Cells Using the OptoSeq™ Single Cell 3′ mRNA Library Kit
Watch this on-demand webinar from Dr. Jason McEwen, our Associate Director of Biology, as he walks you through how our OptoSeq™ Single Cell 3′ mRNA Library Kit will empower you to link differential gene expression data to single precious cells.
App Note: Perform Multi-omic Analysis to Directly Link T Cell Polyfunctionality to Gene Expression
Download this application note to learn about designing effective therapeutics by directly linking phenotype to gene expression using the OptoSeq™ Single Cell 3ʹ mRNA kit in the Opto™ Cell Therapy Development workflow.
App Note: Discover Lead Molecules Against Difficult Targets Inaccessible by Hybridoma Methods
Download this application note to learn about how the Opto™ Plasma B Discovery workflow increases hit recovery for difficult membrane-bound targets and provides access to greater sequence diversity when compared to traditional hybridoma methods.
App Note: FDA-Accepted Monoclonality Assurance on the Beacon® Optofluidic System for Cell Line Development
Learn how the Beacon system’s superior cloning technology, automated imaging capabilities, and in-process quality controls provide definitive evidence of monoclonality to support regulatory approvals.